Test Price
800 AED✅ Home Collection Available
Quantitative Fluorescence PCR (QF‑PCR) Panel for Chromosomes 13, 18, 21, and XY
Executive Summary & Core Metrics
Rapid, Accurate Prenatal Aneuploidy Screening
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The QF‑PCR Panel for chromosomes 13, 18, 21, and XY provides rapid and highly accurate prenatal screening for common aneuploidies and sex chromosome abnormalities from amniotic fluid, chorionic villi, or cord blood samples. This genetic test is essential for high‑risk pregnancies and is backed by DHA guidelines and ISO‑certified laboratory protocols.
| Feature | Our QF‑PCR Panel | Standard Karyotyping |
|---|---|---|
| Diagnostic Precision | >99.9% for targeted aneuploidies | High, but lower resolution for microdeletions |
| Methodology | Quantitative Fluorescence PCR + Sanger Sequencing confirmation | Cell culture and Giemsa banding |
| Turnaround Time | 1 – 2 days | 10 – 14 days |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand the importance of rapid prenatal screening. The QF‑PCR panel provides initial results quickly, but any positive finding requires confirmation and genetic counseling to guide further management. This test is a critical first step in high‑risk pregnancies.”
— Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Advisory Precautions
Medication Warning
Do not discontinue any prescribed pregnancy medications, hormonal supplements, or prenatal vitamins without explicit instruction from your treating physician. Abrupt changes can risk maternal and fetal health.
Patient Exclusion Criteria & ER Red Flags
- Any invasive sample collection (amniocentesis/CVS) should be avoided if there is active vaginal infection or unexplained bleeding.
- Test not typically recommended before 10 completed weeks of gestation.
- Emergency Red Flags: Seek immediate medical attention if you experience vaginal bleeding, fluid leakage, severe abdominal pain, or fever >38°C after sample collection.
Patient FAQ & Clinical Guidance
1. What is the QF‑PCR Panel for chromosomes 13, 18, 21, and XY?
QF‑PCR rapidly detects common aneuploidies of chromosomes 13, 18, 21, and XY using quantitative fluorescence analysis. It provides a preliminary result within 1–2 days, enabling timely clinical decisions. The test targets high‑risk pregnancies where speed is critical.
2. How is the sample collected for the QF‑PCR Panel?
The sample is collected via amniocentesis, chorionic villus sampling, or cordocentesis under ultrasound guidance by a specialist. Each method involves a fine needle and is performed in a hospital setting with strict sterile precautions. Collection is limited to accredited hospital facilities; home phlebotomy is not available for this test.
3. What does a positive result on the QF‑PCR Panel indicate?
A positive result indicates the presence of an extra chromosome, requiring confirmation with clinical correlation and genetic counseling. Further invasive or non‑invasive testing may be recommended to validate the finding and assess fetal prognosis.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Governance
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access‑controlled, and processed on secure servers within UAE jurisdiction. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds DHA Facility License No. 1143 and operates under the corporate branding of DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | Quantitative Fluorescence PCR (QF‑PCR) Panel for Chromosomes 13, 18, 21, and XY |
| Price (AED) | 800 AED |
| Turnaround Time | 1 – 2 Business Days |
| Sample Type / Matrix | Amniotic Fluid, Chorionic Villi, or Cord Blood (Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.) |
| Methodology Used | Quantitative Fluorescence PCR (QF-PCR) with Sanger Sequencing confirmation |
| ICD-10-CM Code | Z36.0 |
| LOINC Code | 82134-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians